NIH to invest an additional $515M for long COVID research
By
John Roszkowski
Feb 16, 2024
The National Institutes of Health has announced plans to provide an additional $515 million in funding over the next four years for the research and treatment of long COVID.
NIH: Two drugs most effective in treating type 2 diabetes
By
John Roszkowski
Sep 23, 2022
Two popular drugs used to treat type 2 diabetes outperformed other medications in managing glucose levels and keeping people with type 2 diabetes healthy, according to new research funded by the National...
Clinical briefs for Tuesday, Feb. 21
By
John Roszkowski
Feb 21, 2023
Omicron hospital illness 54% deadlier than flu, study finds … Drug linked to lower risk of dementia for people with diabetes … Moderna announces plan for no-cost COVID vaccine … Scientists move closer...
Clinical briefs for Monday, Aug. 14
By
John Roszkowski
Aug 14, 2023
Playing football may increase Parkinson’s risk … Researchers discover therapeutic target for Alzheimer’s disease … NIH trials fail to deliver meaningful long COVID treatments … Research looks...
Clinical briefs for Friday, Nov. 4
By
John Roszkowski
Nov 04, 2022
Treatment found effective for patients with chronic kidney disease … Scientists develop new mathematical model of Alzheimer’s disease … Biden to overhaul Medicare Shared Savings Program … NIH backs...
Clinical briefs for Monday, March 25
By
John Roszkowski
Mar 25, 2024
Long genes linked to aging … Fat buildup in brain cells may cause Alzheimer’s … Drug shows no benefit for dry age-related macular degeneration in NIH trial … Neurologic disease may be higher for...
Medicare, Medicaid to cover weight loss drug for heart disease risk
By
John Roszkowski
Mar 25, 2024
The Centers for Medicare & Medicaid Services disclosed last week it will provide coverage for the popular weight loss drug Wegovy for patients at high risk for cardiovascular disease and stroke.
Hypertension drug does not pose health risks, study finds
By
John Roszkowski
Oct 13, 2023
New research suggests that a drug commonly used to treat hypertension is not dangerous, despite the concerns of some clinicians and researchers about potential health risks.
CMS names 10 drugs slated for Medicare price negotiation
By
John Roszkowski
Aug 30, 2023
The Biden administration announced Tuesday the first 10 prescription drugs that would be selected for negotiation under the Medicare Drug Price Negotiation Program designed to lower the costs of prescription...
New Alzheimer’s drug shows promise in slowing disease
By
John Roszkowski
Sep 29, 2022
In a potentially significant breakthrough in the treatment of Alzheimer’s disease, recently completed clinical trials show a new experimental drug treatment could significantly slow the progression of...